R 82913;[5S,(+)]-4,5,6,7-Tetrahydro-9-chloro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione;4,5,6,7-Tetrahydro-5α-methyl-6-(3-methyl-2-butenyl)-9-chloroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione;9-Chloro TIBO;TIBO-R82913;TIBO-R-82913;(+)-(S)-4,5,6,7-tetrahydro-9-chloro-5-methyl-6-(3-methyl-2-butenyl)imidazo<4,5,1-jk><1,4>benzodiazepine-2(1H)-thione;9-Cl-Tibo
R82913 (9-Cl-TIBO) is a potent and highly selective inhibitor of HIV-1 reverse transcriptase, exhibiting antiviral activity against both RNA templates (negative-strand synthesis) and DNA templates (positive-strand synthesis); it inhibits the replication of various strains of HIV-1 in CEM cells with an IC50 value of 0.15 μM.